| scholarly article | Q13442814 |
| P2093 | author name string | Sean M Bagshaw | |
| Sonal Asthana | |||
| Constantine J Karvellas | |||
| Andreas Kremer | |||
| Mark Swain | |||
| Noel Gibney | |||
| Luiz F Lisboa | |||
| P2860 | cites work | TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain | Q24310057 |
| Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure | Q24676985 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Lysophosphatidic acid is a potential mediator of cholestatic pruritus | Q28285205 | ||
| Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A | Q28294740 | ||
| Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus | Q28742619 | ||
| Therapy of intractable pruritus with MARS. | Q33366065 | ||
| Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity | Q34090036 | ||
| Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis | Q34172340 | ||
| Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. | Q34189190 | ||
| Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis | Q34324928 | ||
| Measurement of lysophospholipase D/autotaxin activity in human serum samples. | Q51770493 | ||
| The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. | Q53651902 | ||
| A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. | Q54426503 | ||
| Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study | Q61854318 | ||
| Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis | Q68082565 | ||
| A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid | Q72189521 | ||
| Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC | Q72789964 | ||
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver | Q73715566 | ||
| Open-label trial of oral nalmefene therapy for the pruritus of cholestasis | Q74310569 | ||
| Distinct serum cytokines in AIDS-related skin diseases | Q77214533 | ||
| Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS) | Q79847060 | ||
| Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. | Q34345927 | ||
| Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. | Q34411089 | ||
| Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). | Q34458380 | ||
| Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment | Q34999687 | ||
| Recent advances on T-cell regulation by receptor tyrosine kinases | Q36146652 | ||
| Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. | Q36685758 | ||
| Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports | Q37140216 | ||
| Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus | Q37411966 | ||
| Chronic pruritus – pathogenesis, clinical aspects and treatment | Q37789400 | ||
| Egr-2 and Egr-3 are negative regulators of T cell activation. | Q38327900 | ||
| 'Out-patient' albumin dialysis for cholestatic patients with intractable pruritus | Q38460458 | ||
| Management of sepsis during MARS treatment in acute on chronic liver failure. | Q38463461 | ||
| Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. | Q38467441 | ||
| Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. | Q38471069 | ||
| Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. | Q38473199 | ||
| MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study | Q38473987 | ||
| Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency | Q38482172 | ||
| Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). | Q38482468 | ||
| The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. | Q38486635 | ||
| The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation | Q38488357 | ||
| Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. | Q38489634 | ||
| Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases. | Q38490835 | ||
| Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. | Q38492229 | ||
| Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome | Q38493108 | ||
| Case report of the first Severe Acute Respiratory Syndrome patient in China: successful application of extracorporeal liver support MARS therapy in multiorgan failure possibly induced by Severe Acute Respiratory Syndrome | Q38493144 | ||
| Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). | Q38495277 | ||
| Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. | Q39595436 | ||
| Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis. | Q39966454 | ||
| A controlled trial of naloxone infusions for the pruritus of chronic cholestasis | Q41142015 | ||
| Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial | Q41673941 | ||
| The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial | Q42947273 | ||
| Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. | Q44573504 | ||
| Intractable pruritus in patients with hepatitis C virus | Q45415935 | ||
| Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis | Q46945487 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular adsorbent recirculating system | Q111183344 |
| P304 | page(s) | 799-805 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Canadian Journal of Gastroenterology | Q15749648 |
| P1476 | title | Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series | |
| P478 | volume | 26 |
| Q53346780 | A New Application for Albumin Dialysis in Extracorporeal Organ Support: Characterization of a Putative Interaction Between Human Albumin and Proinflammatory Cytokines IL-6 and TNFα. |
| Q92360170 | Clinical effectiveness of MARS treatment - multidirectional analysis of positive clinical response to treatment |
| Q38448492 | Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report |
| Q92322552 | Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse |
| Q38210112 | Pruritus in cholestasis: facts and fiction. |
Search more.